macro14 October 2026 at 09:16 UTCAnand Rathi Advises Subscribing to Sahajanand Medical Technologies IPOAnand Rathi rates the Sahajanand Medical Technologies IPO as a long-term subscribe, citing its cardiovascular device business and upper-band valuation.IPOPublic OfferingIndia1 source · moneycontrol.com